Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Diabetic Macular Edema
Pharma
EyePoint's Duravyu bounces back with promising DME data
EyePoint revitalized its star asset Duravyu with strong diabetic macular edema data, opening a path forward for other potential retinal indications.
Fraiser Kansteiner
Oct 28, 2024 1:11pm
Roche's eye disease meds Vabysmo, Susvimo show extended efficacy
Jul 18, 2024 11:37am
FDA gives thumbs-up to Roche's Vabysmo in a prefilled syringe
Jul 8, 2024 10:35am
Roche's soaring Vabysmo sales challenge Regeneron's Eylea
May 10, 2024 12:01pm
Ad astra: Regeneron launches stargazing-themed Eylea HD campaign
Mar 20, 2024 10:46am
Regeneron touts 'favorable' physician reports on Eylea HD
Feb 2, 2024 11:09am
